Inclusion Criteria:  Age range: from 16 years to 21 years of age Type 1 Diabetes Mellitus (Anti-body positive) for at least one year Suboptimal glycemic control (HBA1C > 8.5%) in the last 6 months Patients on insulin regimen involving multiple daily subcutaneous insulin injections (basal- bolus regimen) or insulin pumps (excluding hybrid close loop pumps)  Exclusion Criteria:  Non-English-Speaking patients Patients on insulin regimen involving mixed insulin with twice daily injections Patients who are planning to undergo any change in their insulin delivering technology or glucose monitoring device during the study time period i.e. planning initiation or discontinuation of pump or Continuous Glucose Meter. Patients who received new onset DM teaching at another institution and transferred care from other institutions later in their disease course. Individuals with other chronic medical conditions or underlying mental health conditions like eating disorders, schizophrenia or severe depression or inability to care for themselves in activities of daily living (ADLs), or impaired ability to participate in the research in the discretion of their primary diabetes provider. Patients lacking accessibility of a virtual platform for the intervention modules for a 3-month Patients with no visit with Diabetes care provider within the 6 months prior to screening for study eligibility Pregnancy (only if subject, at the time of recruitment, reports being pregnant or planning a pregnancy in the next 6 months. Pregnancy tests will not be performed as part of the study).